Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tera Mayer"'
Autor:
Noah A. Brown, Alexandra C. Hristov, Ryan A. Wilcox, Tycel Phillips, Philip S. Boonstra, Avery Polk, Mark S. Kaminski, Nathanael G. Bailey, Tera Mayer, Sumana Devata
Publikováno v:
American Journal of Hematology. 92:1287-1294
The transcription factor GATA-3, highly expressed in many cutaneous T-cell lymphoma (CTCL) and peripheral T-cell lymphomas (PTCL), confers resistance to chemotherapy in a cell-autonomous manner. As GATA-3 is transcriptionally regulated by NF-κB, we
Publikováno v:
Annals of Lymphoma. 3:12-12
A 54 years old gentleman presented with lymphomatoid granulomatosis (LyG), an EBV-driven lymphoproliferative disorder associated with angiocentric invasion and expansion of EBV positive B cells. He ultimately developed biopsy-confirmed recurrent dise
Autor:
Tera Mayer, Deeter R. Neumann, Bernard L. Marini, Ryan A. Wilcox, Anna Brown, Tycel Phillips, Anthony J. Perissinotti
Publikováno v:
Leukemialymphoma. 59(7)
Natural Killer/T cell (NK/T cell) lymphoma is a rare, yet aggressive T cell lymphoma, which often displays resistance to traditional chemotherapies. Asparagainse (ASNase), through its unique mechanism of action, has become a vital component in the tr
Autor:
Ryan A. Wilcox, Sumana Devata, Tera Mayer, Janie Y. Zhang, Mark S. Kaminski, Tycel Phillips, Nathanael G. Bailey, Robert Briski
Publikováno v:
American journal of hematology. 93(3)
Optimal salvage therapy for primary refractory peripheral T-cell lymphomas (PTCL) and the role of hematopoietic stem cell transplant (SCT) remain poorly defined. We conducted a retrospective review of clinical outcomes and prognostic factors in a sin
Autor:
Tera Mayer, Nathanael G. Bailey, Ryan A. Wilcox, Sumana Devata, Tycel Phillips, Mark S. Kaminski, Robert Briski, Janie Y. Zhang
Publikováno v:
Blood. 128:4152-4152
Background: Resistance to conventional anthracycline-based regimens (CHOP/CHOEP) and the emergence of primary refractory disease remains a clinical challenge in PTCL, and is observed in ≈25% of patients. Outcomes in the setting of primary refractor